相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia- induced hepatocellular carcinoma progression
Jun Wang et al.
JOURNAL OF CANCER (2021)
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
Xue Wen et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Jin Zhang et al.
THERANOSTICS (2020)
HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma
Hee Doo Yang et al.
HEPATOLOGY (2019)
Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1
Yi Yang et al.
LIFE SCIENCES (2019)
Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer
Jun Zhao et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
Chiao-Ling Tsai et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma
Li-Ting Wang et al.
ONCOTARGET (2017)
Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma
Huanlin Wang et al.
HUMAN PATHOLOGY (2017)
Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis
Emanuely Silva Chrun et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway
Long-Kuan Ran et al.
CLINICAL CANCER RESEARCH (2016)
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Valery Vilchez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis
Yuming Li et al.
ONCOTARGET (2016)
HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma
Reena Buurman et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2016)
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons
Antoine Hollebecque et al.
EUROPEAN JOURNAL OF CANCER (2015)
HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population
Ser Yeng Ler et al.
ONCOLOGY REPORTS (2015)
Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
Chong Hao et al.
BMC CANCER (2014)
Prolyl-4-hydroxylase a subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition
Gaofeng Xiong et al.
BMC CANCER (2014)
HDAC2 Provides a Critical Support to Malignant Progression of Hepatocellular Carcinoma through Feedback Control of mTORC1 and AKT
Ji Heon Noh et al.
CANCER RESEARCH (2014)
Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest
Jian Fan et al.
TUMOR BIOLOGY (2014)
Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification
Chungang Liu et al.
CANCER LETTERS (2013)
The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma
Jian Wu et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3/-catenin signaling
Juan Chen et al.
HEPATOLOGY (2013)
SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells
Bo Zhang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2013)
SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
Hsieh-Cheng Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation
Yuan-Yuan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells
Kiminori Kanno et al.
ONCOLOGY REPORTS (2012)
SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
Kyu Yun Jang et al.
PLOS ONE (2012)
Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
Chris Zhiyi Zhang et al.
PLOS ONE (2012)
Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
Li-Ming Wu et al.
PLOS ONE (2010)
Surveillance for hepatocellular carcinoma: in whom and how?
Hashem B. El-Serag et al.
Therapeutic Advances in Gastroenterology (2010)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma
Tatsuya Rikimaru et al.
ONCOLOGY (2007)
分享论文
